Healthy Extracts (HYEX) Other Non-Current Assets (2015 - 2025)
Healthy Extracts' (HYEX) quarterly Other Non-Current Assets came in at $99767.0 in Q4 2025, down 99.59% quarter-over-quarter from $24.5 million in Q3 2025.
Healthy Extracts (HYEX) Other Non-Current Assets (2015 - 2025) Analysis & Trends
Healthy Extracts' Other Non-Current Assets history runs 11 years deep, the most recent figure standing at $99767.0 for Q4 2025.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $99767.0 in Q4 2025; TTM through Dec 2025 was $99767.0, a N/A change from a year earlier, with the FY2025 full-year figure at $99767.0, changed N/A from the prior year.
- Other Non-Current Assets declined to $99767.0 in Q4 2025 per HYEX's latest filing, from $24.5 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $24.5 million in Q3 2025 and bottomed at $16890.0 in Q1 2022.
- The 5-year median for Other Non-Current Assets is $716175.0 (2021), against an average of $1.8 million.
- Across the five-year window, Other Non-Current Assets jumped 4255.71% in 2024 and sank 97.7% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $716175.0 in 2021, then advanced by 2.98% to $737531.0 in 2022, then fell by 0.3% to $735336.0 in 2023, then climbed by 0.05% to $735679.0 in 2024, then slumped by 86.44% to $99767.0 in 2025.
- Per Business Quant, the three latest HYEX Other Non-Current Assets figures stand at $99767.0 (Q4 2025), $24.5 million (Q3 2025), and $934894.0 (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Healthy Extracts | 14.70 Mn | 14.56 Mn | 957,429.00 | 99,767.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 99,767.00 |
| Sep 30, 2025 | 24.46 Mn |
| Jun 30, 2025 | 934,894.00 |
| Mar 31, 2025 | 16,890.00 |
| Sep 30, 2024 | 735,679.00 |
| Jun 30, 2024 | 735,883.00 |
| Mar 31, 2024 | 734,787.00 |
| Dec 31, 2023 | 735,336.00 |
| Sep 30, 2023 | 16,890.00 |
| Jun 30, 2023 | 736,434.00 |
| Mar 31, 2023 | 85,632.00 |
| Dec 31, 2022 | 737,531.00 |
| Sep 30, 2022 | 16,890.00 |
| Jun 30, 2022 | 738,629.00 |
| Mar 31, 2022 | 16,890.00 |
| Dec 31, 2021 | 716,175.00 |
| Sep 30, 2021 | 706,334.00 |
| Jun 30, 2021 | 696,109.00 |
| Mar 31, 2021 | 661,884.00 |
| Dec 31, 2020 | 625,272.00 |